Developer docs
API playgroundTry for free, no card

Search company profiles

Intouch Group

Full company profile

uuid000dbka

Namestring
Intouch Group
Legal namestring
EVERSANA INTOUCH
Websiteurl
intouchg.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

EVERSANA INTOUCH (formerly Intouch Group) is a full-service agency network serving life sciences companies, headquartered in Overland Park, United States, and operating as a wholly-owned subsidiary of EVERSANA. Founded in 2018 and employing between 1,001 and 5,000 people, the company generates revenue through professional services engagements with enterprise pharmaceutical, biotech, and life sciences clients. Its service portfolio spans brand planning, omnichannel activation, content transformation, medical communications, market access, and media services, with go-to-market executed via direct enterprise field sales and custom-quoted engagements.

The company's core offering is a platform-plus-specialty architecture organized around the "EVERSANA INTOUCH One Agency" hub and four specialty divisions: HealthwareGlobal (global marketing), MedComm (medical communications), Market Access, and Media. The unifying layer is an AI-powered operating model that combines artificial intelligence with human expertise to integrate strategy, creative, execution, and data into a single workflow, replacing the fragmented agency handoffs common in pharma commercialization. Its flagship proprietary technology, AIVI, is an AI-powered patient identification tool demonstrated in a gastroparesis case study to surface 1.8 million additional undiagnosed patients, providing a quantified anchor for the company's AI differentiation claim.

Commercially, the firm sells custom-priced enterprise engagements to business units within pharmaceutical and life sciences companies, supported by thought leadership channels (annual Brand Planning Report, Mind + Machine webinars, industry blog, LinkedIn/Facebook/Twitter/Instagram presence). As a subsidiary of EVERSANA, the company does not have independent venture or private equity funding, and its financial results are consolidated within EVERSANA's broader commercial solutions platform. No standalone revenue, ARR, or growth rate is disclosed in the available source data.

Short descriptiontext

EVERSANA INTOUCH (formerly Intouch Group) is a full-service pharma marketing agency network providing AI-powered brand planning, omnichannel activation, medical communications, market access, and media services to enterprise life sciences companies, operating as a subsidiary of EVERSANA.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersOverland Park, United States
HQ citystring
Overland Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical marketing services, life sciences commercialization, medical communications agency, market access services, omnichannel brand activation
NAICS code1 code
  • Advertising Agencies541810
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Marketing & Life Sciences Commercialization Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Agency Services Revenue
TypeProfessional Services
Description

EVERSANA INTOUCH generates revenue through providing full-service marketing agency services to life sciences companies, including brand planning, omnichannel activation, content transformation, medical communications, market access, and media services. The company operates as a professional services firm serving pharmaceutical and healthcare clients.

eversanaintouch.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Healthware
Description

Global Marketing Specialty division of EVERSANA INTOUCH

eversanaintouch.com
+3 more records
Core offering1 text field

EVERSANA INTOUCH (formerly Intouch Group) is a full-service agency network serving life sciences companies, delivering strategy, creative, execution, and data through an AI-powered operating model. It operates specialty practices in global marketing (HealthwareGlobal), medical communications (MedComm), market access, and media, supporting brand planning, omnichannel activation, content transformation, and innovation for pharmaceutical and biotech clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Identified 1.8M additional undiagnosed patients using AIVI technology
Product overview1 text field

EVERSANA INTOUCH is a full-service agency network organized as a unified platform-plus-specialty architecture. The core EVERSANA INTOUCH One Agency serves as the central hub, supported by five specialized sub-brands: HealthwareGlobal (global marketing), MedComm (medical communications), Market Access, and Media. Additional service modules include Brand Planning, Omnichannel Activation, Content Transformation, and Innovation Services. The network replaces fragmented agency handoffs with a single, AI-powered operating model built specifically for life sciences commercialization, unifying strategy, creative, execution, and data.

Product and service8 records
1EVERSANA INTOUCH One Agency
CategoryFull-service agency network
Description

Primary full-service agency network that unifies strategy, creative, execution, and data with AI and human expertise to deliver measurable business impact at enterprise scale for life sciences commercialization clients.

2EVERSANA INTOUCH HealthwareGlobal
CategorySpecialty practice — Global marketing
Description

Global marketing specialty providing comprehensive marketing solutions for life sciences brands seeking international commercialization support.

3EVERSANA INTOUCH MedComm
CategorySpecialty practice — Medical communications
Description

Medical communications specialty offering expertise in scientific communication and medical education for life sciences clients.

4EVERSANA INTOUCH Market Access
CategorySpecialty practice — Market access
Description

Market access specialty helping clients navigate pricing, reimbursement, and payer strategies for pharmaceutical products.

5EVERSANA INTOUCH Media
CategorySpecialty practice — Media
Description

Media specialty focused on media planning, buying, and activation across channels for life sciences brands.

6Brand Planning Services
CategoryService module — Strategy
Description

Strategic brand planning services to fuel brand plan success through AI-powered integration for pharmaceutical and biotech clients.

7Omnichannel Activation
CategoryService module — Activation
Description

Multi-channel campaign activation services connecting strategy, creative, execution, and data for life sciences brands.

8Content Transformation
CategoryService module — Content
Description

Services to transform and optimize content for multi-channel distribution and engagement for life sciences brands.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EVERSANA INTOUCH is part of the EVERSANA family, a fully integrated commercial solutions organization. EVERSANA provides the broader platform while INTOUCH serves as the full-service agency network component, combining commercialization expertise with marketing agency capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Publicis Groupe's dedicated healthcare marketing and communications network. Direct competitor offering the same full-service agency model (brand strategy, medical communications, market access, omnichannel activation) for the same pharma and biotech client base. Closest peer in scale and scope.

TypeDirect peer
Description

Independent healthcare marketing and communications agency with comparable full-service offerings including brand strategy, creative, data/analytics, and medical communications. Comparable in size and customer base (enterprise pharma and biotech) without the parent-holding-company overhead.

TypeDirect peer
Description

Specialist healthcare media planning, buying, and activation agency competing directly with EVERSANA INTOUCH's Media specialty. Comparable in customer base (enterprise pharma) and core media-services offering within the broader healthcare agency landscape.

TypeDirect peer
Description

Houses healthcare-focused agencies including CDM, DDB Health, and Snow Companies under Omnicom. Direct competitor providing full-service pharma commercialization across creative, medical communications, and patient marketing to overlapping enterprise pharma clients.

TypeDirect peer
Description

PE-backed integrated commercialization services platform combining Ashfield Health's medical communications, market access, and creative services with broader commercialization capabilities. Directly comparable as a consolidated, PE-backed healthcare communications and services platform.

TypeDirect peer
Description

Interpublic Group's healthcare communications network including FCB Health, McCann Health, and IPG Mediabrands health. Directly comparable as a multi-specialty pharma agency network serving global enterprise pharma clients with strategy, creative, and medical communications.

TypeBroad incumbent
Description

WPP operates healthcare practices within VMLY&R, Grey, and Ogilvy Health. Broader incumbent holding company with healthcare as one of many verticals — overlaps on services and clients but does not specialize solely in life sciences like INTOUCH does.

TypeDirect peer
Description

Havas' dedicated health and wellness network offering strategy, creative, medical communications, and patient engagement for pharmaceutical clients. Direct competitor in the same healthcare agency category with similar multi-specialty architecture.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Intouch Group

Pharmaceutical Marketing & Life Sciences Commercialization Servicesintouchg.com

EVERSANA INTOUCH (formerly Intouch Group) is a full-service pharma marketing agency network providing AI-powered brand planning, omnichannel activation, medical communications, market access, and media services to enterprise life sciences companies, operating as a subsidiary of EVERSANA.

What Intouch Group does

EVERSANA INTOUCH (formerly Intouch Group) is a full-service agency network serving life sciences companies, headquartered in Overland Park, United States, and operating as a wholly-owned subsidiary of EVERSANA. Founded in 2018 and employing between 1,001 and 5,000 people, the company generates revenue through professional services engagements with enterprise pharmaceutical, biotech, and life sciences clients. Its service portfolio spans brand planning, omnichannel activation, content transformation, medical communications, market access, and media services, with go-to-market executed via direct enterprise field sales and custom-quoted engagements.

The company's core offering is a platform-plus-specialty architecture organized around the "EVERSANA INTOUCH One Agency" hub and four specialty divisions: HealthwareGlobal (global marketing), MedComm (medical communications), Market Access, and Media. The unifying layer is an AI-powered operating model that combines artificial intelligence with human expertise to integrate strategy, creative, execution, and data into a single workflow, replacing the fragmented agency handoffs common in pharma commercialization. Its flagship proprietary technology, AIVI, is an AI-powered patient identification tool demonstrated in a gastroparesis case study to surface 1.8 million additional undiagnosed patients, providing a quantified anchor for the company's AI differentiation claim.

Commercially, the firm sells custom-priced enterprise engagements to business units within pharmaceutical and life sciences companies, supported by thought leadership channels (annual Brand Planning Report, Mind + Machine webinars, industry blog, LinkedIn/Facebook/Twitter/Instagram presence). As a subsidiary of EVERSANA, the company does not have independent venture or private equity funding, and its financial results are consolidated within EVERSANA's broader commercial solutions platform. No standalone revenue, ARR, or growth rate is disclosed in the available source data.

Intouch Group firmographics

Firmographics
Name
Intouch Group
Legal name
EVERSANA INTOUCH
Website
https://intouchg.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
EVERSANA INTOUCH (formerly Intouch Group) is a full-service pharma marketing agency network providing AI-powered brand planning, omnichannel activation, medical communications, market access, and media services to enterprise life sciences companies, operating as a subsidiary of EVERSANA.
Ownership category
akta.pro rank

Where Intouch Group is headquartered

Location

Headquarters

HQ city
Overland Park
HQ country
United States
HQ region
North America

Markets served

Intouch Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Agency Services Revenue: EVERSANA INTOUCH generates revenue through providing full-service marketing agency services to life sciences companies, including brand planning, omnichannel activation, content transformation, medical communications, market access, and media services. The company operates as a professional services firm serving pharmaceutical and healthcare clients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Intouch Group product offering

Product offering

Core offering

EVERSANA INTOUCH (formerly Intouch Group) is a full-service agency network serving life sciences companies, delivering strategy, creative, execution, and data through an AI-powered operating model. It operates specialty practices in global marketing (HealthwareGlobal), medical communications (MedComm), market access, and media, supporting brand planning, omnichannel activation, content transformation, and innovation for pharmaceutical and biotech clients.

Product overview

EVERSANA INTOUCH is a full-service agency network organized as a unified platform-plus-specialty architecture. The core EVERSANA INTOUCH One Agency serves as the central hub, supported by five specialized sub-brands: HealthwareGlobal (global marketing), MedComm (medical communications), Market Access, and Media. Additional service modules include Brand Planning, Omnichannel Activation, Content Transformation, and Innovation Services. The network replaces fragmented agency handoffs with a single, AI-powered operating model built specifically for life sciences commercialization, unifying strategy, creative, execution, and data.

Differentiator

Problem solved

Functional benefit

Brands

  • Healthware: Global Marketing Specialty division of EVERSANA INTOUCH
  • MedComm
  • Market Access
  • Media

Products and services

  • EVERSANA INTOUCH One Agency Primary full-service agency network that unifies strategy, creative, execution, and data with AI and human expertise to deliver measurable business impact at enterprise scale for life sciences commercialization clients.
  • EVERSANA INTOUCH HealthwareGlobal Global marketing specialty providing comprehensive marketing solutions for life sciences brands seeking international commercialization support.
  • EVERSANA INTOUCH MedComm Medical communications specialty offering expertise in scientific communication and medical education for life sciences clients.
  • EVERSANA INTOUCH Market Access Market access specialty helping clients navigate pricing, reimbursement, and payer strategies for pharmaceutical products.
  • EVERSANA INTOUCH Media Media specialty focused on media planning, buying, and activation across channels for life sciences brands.
  • Brand Planning Services Strategic brand planning services to fuel brand plan success through AI-powered integration for pharmaceutical and biotech clients.
  • Omnichannel Activation Multi-channel campaign activation services connecting strategy, creative, execution, and data for life sciences brands.
  • Content Transformation Services to transform and optimize content for multi-channel distribution and engagement for life sciences brands.

Quantifiable outcome

  • Identified 1.8M additional undiagnosed patients using AIVI technology

Companies that use Intouch Group

Customer profile

Segments1 record

Ideal customer profiles1 record

Intouch Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Intouch Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • EVERSANAcoreStrategic or Co-development PartnerEVERSANA INTOUCH is part of the EVERSANA family, a fully integrated commercial solutions organization. EVERSANA provides the broader platform while INTOUCH serves as the full-service agency network component, combining commercialization expertise with marketing agency capabilities.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Intouch Group competitors and assessment

Company assessment

Direct peers

  • Publicis Health: Publicis Groupe's dedicated healthcare marketing and communications network. Direct competitor offering the same full-service agency model (brand strategy, medical communications, market access, omnichannel activation) for the same pharma and biotech client base. Closest peer in scale and scope.
  • Real Chemistry: Independent healthcare marketing and communications agency with comparable full-service offerings including brand strategy, creative, data/analytics, and medical communications. Comparable in size and customer base (enterprise pharma and biotech) without the parent-holding-company overhead.
  • CMI Media Group: Specialist healthcare media planning, buying, and activation agency competing directly with EVERSANA INTOUCH's Media specialty. Comparable in customer base (enterprise pharma) and core media-services offering within the broader healthcare agency landscape.
  • Omnicom Health Group: Houses healthcare-focused agencies including CDM, DDB Health, and Snow Companies under Omnicom. Direct competitor providing full-service pharma commercialization across creative, medical communications, and patient marketing to overlapping enterprise pharma clients.
  • Inizio (Ashfield Health): PE-backed integrated commercialization services platform combining Ashfield Health's medical communications, market access, and creative services with broader commercialization capabilities. Directly comparable as a consolidated, PE-backed healthcare communications and services platform.
  • IPG Health: Interpublic Group's healthcare communications network including FCB Health, McCann Health, and IPG Mediabrands health. Directly comparable as a multi-specialty pharma agency network serving global enterprise pharma clients with strategy, creative, and medical communications.
  • Havas Health & You: Havas' dedicated health and wellness network offering strategy, creative, medical communications, and patient engagement for pharmaceutical clients. Direct competitor in the same healthcare agency category with similar multi-specialty architecture.

Broad incumbents

  • WPP (Health Practice): WPP operates healthcare practices within VMLY&R, Grey, and Ogilvy Health. Broader incumbent holding company with healthcare as one of many verticals — overlaps on services and clients but does not specialize solely in life sciences like INTOUCH does.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Intouch Group social profiles

Digital presence

Intouch Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Intouch Group leadership team

Management profile

Number of profiles

Profiles2 records

Intouch Group subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Intouch Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Intouch Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intouch Group

What does Intouch Group do?

EVERSANA INTOUCH (formerly Intouch Group) is a full-service agency network serving life sciences companies, delivering strategy, creative, execution, and data through an AI-powered operating model. It operates specialty practices in global marketing (HealthwareGlobal), medical communications (MedComm), market access, and media, supporting brand planning, omnichannel activation, content transformation, and innovation for pharmaceutical and biotech clients.

Is Intouch Group a public or private company?

Intouch Group is a private company. It is classified as corporate owned and is currently operating.

When was Intouch Group founded?

Intouch Group was founded in 2018. It employs 1,001 to 5,000 people.

Where is Intouch Group based?

Intouch Group is headquartered in Overland Park, United States, in the North America region.

How does Intouch Group make money?

One revenue line is on record: agency Services Revenue.

Who are Intouch Group's main competitors?

Direct peers on record are Publicis Health, Real Chemistry, CMI Media Group, Omnicom Health Group, Inizio (Ashfield Health), IPG Health and Havas Health & You. WPP (Health Practice) is listed as a broad incumbent.

Does Intouch Group have an API?

No public API is recorded for Intouch Group.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FiercePharmaBeyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth ModelMike Guarino, CEO of EVERSANA INTOUCH, outlines a strategic shift in the life sciences industry where AI and human creativity converge to drive commercial outcomes rather than merely replacing manual work. This approach is exemplified by EVERSANA’s AI-powered platform, developed in partnership with Google, which facilitates both enterprise-scale adoption and incremental workflow integration. The strategy emphasizes using technology to enhance storytelling and critical thinking, aiming to create deeper resonance with the human experience in healthcare.ApplitoolsWhy the Future of Test Automation is Code AND No-CodeThe article argues that combining code-based and no-code test automation strategies offers superior efficiency compared to relying on a single approach, leveraging the precision of code for complex scenarios and the speed of no-code for routine tasks. It highlights EVERSANA INTOUCH as a case study where adopting Applitools tools resulted in a significant reduction in regression testing time and improved cross-team collaboration.PR NewswireEVERSANA INTOUCH Wins Gold at Cannes Lions Festival of CreativityEVERSANA announced that its agency network EVERSANA INTOUCH won a Gold Lion at the Cannes Lions International Festival of Creativity in the Pharma category. The award was for the "Inequality You Can't Ignore" campaign, conducted in partnership with The Chrysalis Initiative, which addresses inequality in breast cancer care for Black women and other disparate groups—one of just 12 Lions awarded in the Pharma category in 2023. The Cannes Lions festival, held annually in Cannes, France, is recognized as one of the world's most prestigious advertising awards, with entries judged from over 90 countries across 28 categories.PR NewswireEVERSANA INTOUCH Wins Five Clio AwardsEVERSANA announced that its agency network EVERSANA INTOUCH won five awards at the 2023 Clio Health Awards, including one gold, one silver, and three bronze, for creative work with The Chrysalis Initiative and the Global Lyme Alliance. CEO Jim Lang called it a testament to the creative capabilities the agency brings to pharmaceutical brands. The Clio Awards, founded in 1959, are a prestigious industry recognition program celebrating creative excellence in advertising.PR NewswireEVERSANA™ Unveils EVERSANA INTOUCH, a Next-Generation Agency Network Delivering Award-Winning Creative, Digital, and Global Market Access Solutions for Life SciencesEVERSANA unveiled EVERSANA INTOUCH, a transformed global healthcare agency network for the life sciences industry formed through the integration of Intouch Group (acquired in December 2021) and EVERSANA ENGAGE. The combined network now includes more than 1,800 marketers across eight North American locations plus over 40 global locations, positioning EVERSANA as a $1 billion commercial services leader. Faruk Capan, founder of Intouch and newly appointed Chief Innovation Officer of EVERSANA, will serve as CEO of EVERSANA INTOUCH.PR NewswireLürzer's Archive Recognizes Intouch Group as a 2021 Top Five Creative AgencyIntouch Group, an EVERSANA company and full-service global agency network serving the pharmaceutical industry, was ranked by Lürzer's Archive as a top five creative advertising agency in the United States and top fifteen globally for 2021, with 11 creative pieces featured in the magazine that year. The recognition highlights the agency's creative and strategic depth, with highlighted campaigns including The Last Plaque, Ticking Lyme Bomb, and Erase the Line. Lürzer's Archive, an internationally celebrated advertising magazine founded in 1984, is headquartered in Vienna, Austria.PR NewswireEVERSANA schließt die Übernahme der Intouch Group ab und fügt dem Marktführer im Bereich der Vermarktung der nächsten Generation das erste Agenturnetzwerk mit digitaler Ausrichtung hinzuEVERSANA announced the completion of its acquisition of Intouch Group, a global full-service agency network for the pharmaceutical industry, on December 22, 2021. The deal strengthens EVERSANA's position as a leading commercial services company valued at $1 billion, operating from over 40 locations with 5,500 employees worldwide. Intouch's creative, media, enterprise solutions, and data analytics services will be integrated into EVERSANA's fully integrated commercialization platform, with additional investments planned for data, analytics, and digital transformation.PR NewswireEVERSANA finalise l'acquisition d'Intouch Group et regroupe ainsi le principal réseau d'agences axé sur le numérique et le leader du marché en matière de commercialisation de prochaine générationEVERSANA has finalized its acquisition of Intouch Group, a transaction announced in October 2021, creating a combined entity with over 40 locations worldwide and nearly 7,000 employees. The acquisition positions EVERSANA as a leader in commercial services valued at $1 billion within the life sciences industry, integrating Intouch's creative, media, and data analytics capabilities into its fully integrated commercialization platform. Financial details of the deal were not disclosed, with Houlihan Lokey serving as exclusive financial advisor to Intouch Group.PR NewswireEVERSANA completa la adquisición de Intouch Group y añade una red de agencias de prioridad digital de primer nivel al líder del mercado de la comercialización de última generaciónEVERSANA announced the completion of its acquisition of Intouch Group, a full-service global agency network serving the pharmaceutical industry, effective December 21, 2021. The transaction immediately strengthens EVERSANA's position as a leader in commercial services for the life sciences industry, creating a USD 1 billion-valued company with more than 40 locations and 5,500 employees worldwide. Financial terms were not disclosed, and Houlihan Lokey served as the exclusive financial advisor to Intouch Group.PR NewswireEVERSANA conclui aquisição do Intouch Group, adicionando a pioneira rede de agências que prioriza o digital à líder de mercado na comercialização de última geraçãoEVERSANA announced the completion of its acquisition of Intouch Group, a global full-service agency network serving the pharmaceutical industry. The deal strengthens EVERSANA's position as a commercial services leader valued at USD 1 billion, with over 40 locations and 5,500 employees worldwide. Faruk Capan, CEO of Intouch Group, will now report to EVERSANA CEO Jim Lang, and agencies from both companies will integrate under EVERSANA ENGAGE.